Amyloid heart disease: a brief review of treatment options

Area of Science:

• Cardiology
• Hematology
• Genetics

Background:

• Cardiac amyloidosis is a complex systemic disease.
• Accurate diagnosis of amyloid type is essential for effective treatment selection.
• Treatment strategies involve managing restrictive cardiomyopathy and addressing the underlying amyloidogenic cause.

Purpose of the Study:

• To provide a schematic overview of therapeutic options for various amyloidosis types affecting the heart.
• To highlight the critical role of diagnosis in guiding treatment decisions.
• To discuss the complexities of managing cardiac amyloidosis, including chemotherapy and transplantation.

Main Methods:

• Review of current therapeutic strategies for different forms of amyloidosis.
• Discussion of conventional management of restrictive cardiomyopathy.
• Exploration of targeted therapies for the amyloidogenic process.

Main Results:

• Treatment varies significantly based on amyloid type (e.g., AL, hereditary, senile systemic, secondary).
• Light chain (AL) amyloidosis often requires chemotherapy with potential cardiac toxicity.
• Hereditary amyloidosis may necessitate liver transplantation and family screening.
• Multiorgan transplantation and high-dose chemotherapy can be required for advanced cases.

Conclusions:

• Effective management of cardiac amyloidosis requires a tailored approach based on the specific amyloid type.
• Therapeutic decisions must balance treatment efficacy with potential toxicities.
• Multidisciplinary care involving cardiology, hematology, and transplantation is often necessary.